Effect of black tea consumption on blood cholesterol: A meta-analysis of 15 randomized controlled trials

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wang, Dongmei ^a   Chen, Canhuang ^b   Wang, Yu ^b   Liu, Jiaxing ^b   Lin, Rongkai ^b  

^a Wuhan No161 Hospital   (China)

^b Health Management Center No 180 Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK TEA EXTRACT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYPHENOL; TEA;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; FIXED EFFECTS ANALYSIS; HUMAN; JADAD SCORE; META ANALYSIS; OUTCOME ASSESSMENT; PUBLISHING; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOM EFFECTS ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STUDY DESIGN; TEA; TREATMENT DURATION; ADULT; AGED; BLOOD; CAMELLIA SINENSIS; CHEMISTRY; MIDDLE AGED;

CAMELLIA SINENSIS;

ADULT; AGED; CAMELLIA SINENSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; HUMANS; MIDDLE AGED; POLYPHENOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; TEA;

EID: 84907199489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107711     Document Type: Article

References (48)

1. World Health Organization (2012) Cardiovascular Disease: Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, Switzerland: WHO, 2012.
2. Smith SC Jr., Collins A, Ferrari R., Holmes DR Jr, Logstrup S, et al. (2012) Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). J Am Coll Cardiol 60: 2343-2348.
3. World Health Organization and World Economic Forum (2011) From Burden to "Best Buys": Reducing the Economic Impact of NCDs in Lowand Middle-Income Countries. Geneva, Switzerland: WHO, 2011.
4. Wilson PW, D'Agostino RB, Levy D, Belanger A.M., Silbershatz H., et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847.
5. Assmann G, Schulte H, von E.A., Huang Y. (1996) High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124 Suppl: S11-20.
6. Stamler J, Wentworth D, Neaton J.D. (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828.
7. (1984) The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365-374.
8. Wilson PW, Garrison RJ, Castelli W.P., Feinleib M., McNamara PM, et al. (1980) Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 46: 649-654.
9. Lloyd-Jones D., Adams RJ, Brown T.M., Carnethon M., Dai S, et al. (2010) Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121: e46-46e215.
10. Gyarfas I, Keltai M, Salim Y. (2006) [Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries in a case-control study based on the INTERHEART study]. Orv Hetil 147: 675-686.
11. Brunner E, White I, Thorogood M., Bristow A, Curle D, et al (1997) Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Am J Public Health 87: 1415-1422.
12. Kastorini CM, Milionis HJ, Esposito K, Giugliano D., Goudevenos JA, et al. (2011) The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534, 906 individuals. J Am Coll Cardiol 57: 1299-1313.
13. Song WO, Chun O.K. (2008) Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr 138: 1543S-1547S.
14. Deka A, Vita J.A. (2011) Tea and cardiovascular disease. Pharmacol Res 64: 136-145.
15. Zheng XX, Xu YL, Li S.H., Liu XX, Hui R, et al. (2011) Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr 94: 601-610.
16. Peters U, Poole C, Arab L. (2001) Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 154: 495-503.
17. Hartley L, Flowers N, Holmes J., Clarke A, Stranges S, et al (2013) Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 6: CD009934.
18. Zhao Y, Asimi S, Wu K., Zheng J, Li D. (2014) Black tea consumption and serum cholesterol concentration: Systematic review and meta-analysis of randomized controlled trials. LID - S0261-5614(14)00167-8 [pii]LID - 10.1016/j.clnu.2014.06.003 [doi]. Clin Nutr.
19. Moher D, Pham B, Jones A., Cook DJ, Jadad AR, et al. (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet 352: 609-613.
20. Liu K, Xing A, Chen K., Wang B, Zhou R, et al (2013) Effect of fruit juice on cholesterol and blood pressure in adults: a meta-analysis of 19 randomized controlled trials. PLOS ONE 8: e61420.
21. Higgins JP, Thompson SG, Deeks J.J., Altman D.G. (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
22. Follmann D, Elliott P, Suh I., Cutler J. (1992) Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45: 769-773.
23. Bahorun T, Luximon-Ramma A, Neergheen-Bhujun VS, Gunness TK, Googoolye K, et al (2012) The effect of black tea on risk factors of cardiovascular disease in a normal population. Prev Med 54 Suppl: S98-102.
24. Kubota K, Sumi S, Tojo H., Sumi-Inoue Y, I-Chin H, et al. (2011) Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res 31: 421-428.
25. Neyestani TR, Shariatzade N, Kalayi A., Gharavi A, Khalaji N, et al (2010) Regular daily intake of black tea improves oxidative stress biomarkers and decreases serum C-reactive protein levels in type 2 diabetic patients. Ann Nutr Metab 57: 40-49.
26. Trautwein EA, Du Y, Meynen E., Yan X, Wen Y, et al (2010) Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Eur J Nutr 49: 27-35.
27. Fujita H, Yamagami T. (2008) Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 28: 450-456.
28. Mukamal KJ, MacDermott K, Vinson J.A., Oyama N., Manning WJ, et al. (2007) A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 154: 724. e1-6.
29. Hodgson JM, Burke V, Beilin L.J., Croft KD, Puddey I.B. (2003) Can black tea influence plasma total homocysteine concentrations. Am J Clin Nutr 77: 907-911.
30. Davies MJ, Judd JT, Baer D.J., Clevidence BA, Paul DR, et al. (2003) Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 133: 3298S-3302S.
31. Hodgson JM, Puddey IB, Burke V, Watts G.F., Beilin L.J. (2002) Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 102: 195-201.
32. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff P.L., et al. (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104: 151-156.
33. Duffy SJ, Vita JA, Holbrook M, Swerdloff P.L., Keaney JF Jr (2001) Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21: 1084-1089.
34. Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C., Tijburg LB, et al. (1998) No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 18: 833-841.
35. Ishikawa T, Suzukawa M, Ito T., Yoshida H, Ayaori M, et al (1997) Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 66: 261-266.
36. Bingham SA, Vorster H, Jerling J.C., Magee E., Mulligan A, et al. (1997) Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 78: 41-55.
37. van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, et al (1997) Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 66: 1125-1132.
38. Wang ZM, Zhou B, Wang Y.S., Gong QY, Wang QM, et al. (2011) Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr 93: 506-515.
39. Mineharu Y, Koizumi A, Wada Y., Iso H, Watanabe Y, et al (2011) Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 65: 230-240.
40. Satoh E, Tohyama N, Nishimura M. (2005) Comparison of the antioxidant activity of roasted tea with green, oolong, and black teas. Int J Food Sci Nutr 56: 551-559.
41. Balentine DA, Wiseman SA, Bouwens L.C. (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37: 693-704.
42. Shahidi F (2000) Antioxidants in food and food antioxidants. Nahrung 44: 158-163.
43. Stangl V, Lorenz M, Stangl K. (2006) The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res 50: 218-228.
44. Chan PT, Fong WP, Cheung Y.L., Huang Y., Ho WK, et al. (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 129: 1094-1101.
45. Abe I, Seki T, Umehara K., Miyase T, Noguchi H, et al (2000) Green tea polyphenols: novel and potent inhibitors of squalene epoxidase. Biochem Biophys Res Commun 268: 767-771.
46. Carroll MD, Kit BK, Lacher D.A., Yoon S.S. (2013) Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief: 1-8.
47. Friedewald WT, Levy RI, Fredrickson D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
48. Turkalp I, Cil Z, Ozkazanc D. (2005) Analytical performance of a direct assay for LDL-cholesterol: a comparative assessment versus Friedewald's formula. Anadolu Kardiyol Derg 5: 13-17.